⌘K

Login Start Free

Home/Filings/4/0001607062-18-000351

4//SEC Filing

Ro Andrew 4

Accession 0001607062-18-000351

CIK 0001059784other

View on SEC.gov Company Profile

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 4:18 PM ET

Size

5.1 KB

Accession

0001607062-18-000351

Insider Transaction Report

Form 4

Period: 2018-10-03

GENEREX BIOTECHNOLOGY CORPGNBT

DirectorSVP & Chief Investment Officer

Transactions

Award
Stock Option (right to buy)
2018-10-03+4,500→ 4,500 total
Exercise: $2.23Exp: 2028-10-03→ Common Stock (4,500 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments beginning on October 3, 2018.

Documents

1 file

4
ownership.xmlPrimary

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeother

Related Parties

1

filerCIK 0001755880

Filing Metadata

Form type: 4
Filed: Oct 14, 8:00 PM ET
Accepted: Oct 15, 4:18 PM ET
Size: 5.1 KB

View on SEC.gov